Windtree Therapeutics, Inc. (WINT)
NASDAQ: WINT · Real-Time Price · USD
0.8988
-0.0106 (-1.17%)
At close: May 13, 2025, 4:00 PM
0.9001
+0.0013 (0.14%)
Pre-market: May 14, 2025, 7:00 AM EDT
Windtree Therapeutics Employees
Windtree Therapeutics had 14 employees as of December 31, 2024. The number of employees decreased by 6 or -30.00% compared to the previous year.
Employees
14
Change
-6
Growth
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$391,929
Market Cap
3.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
WINT News
- 1 day ago - Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025 - GlobeNewsWire
- 7 days ago - Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US - GlobeNewsWire
- 6 weeks ago - Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics - PRNewsWire
- 7 weeks ago - Evofem Reports Fourth Consecutive Year of Net Sales Growth - PRNewsWire
- 7 weeks ago - Windtree Therapeutics Regains Compliance with Nasdaq Listing Rules - GlobeNewsWire
- 7 weeks ago - Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product - GlobeNewsWire
- 4 months ago - Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company's Oncology Pipeline - GlobeNewsWire
- 4 months ago - Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - GlobeNewsWire